Autor: |
Yasem Arghide, Azam Faraji, Ali Akbar Vaisi Raygani, Nader Salari, Hamidreza Omrani, Mohammad Mehdi Mohammadi |
Jazyk: |
angličtina |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
Health Science Reports, Vol 6, Iss 11, Pp n/a-n/a (2023) |
Druh dokumentu: |
article |
ISSN: |
2398-8835 |
DOI: |
10.1002/hsr2.1709 |
Popis: |
Abstract Background and Aims Experiencing nausea leads to decreased self‐esteem and social isolation in hemodialysis patients and affects all aspects of their quality of life. Nausea and vomiting make hemodialysis unpleasant for patients leading to premature termination of hemodialysis. Therefore, based on this necessity, the present study was conducted to determine the effect of hemodialysis with cool dialysate on nausea in hemodialysis patients. Methods In this clinical trial, 60 eligible patients receiving hemodialysis were randomly assigned to the control (30 participants) and intervention (30 participants) groups. In the control group, the patients received standard hemodialysis (37°C) for three sessions. Simultaneously, patients in the intervention group received hemodialysis with a cold solution (of 36°C) for three sessions. The patients' nausea and shivering rates were measured using the visual analog scale and the shivering standard assessment scale, respectively. Both groups were evaluated before and after 1 week of intervention. The study did not include blinding. The trial has been registered in the Iranian Registry of Clinical Trials (IRCT) with the number IRCT20200530047597N1. The present study was financially supported by Kermanshah University of Medical Sciences, Kermanshah, Iran (no. 990220). Data were analyzed using SPSS‐25 software. Findings The independent t test showed no statistically significant difference between the two control and experimental groups regarding the nausea rate in the three evaluation times (p |
Databáze: |
Directory of Open Access Journals |
Externí odkaz: |
|